To see the other types of publications on this topic, follow the link: Advantan.

Journal articles on the topic 'Advantan'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Advantan.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

&NA;. "Superior safety with Advantan (Rm)." Reactions Weekly &NA;, no. 445 (1993): 2. http://dx.doi.org/10.2165/00128415-199304450-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

KUNGUROV, N. V., M. M. KOKHAN, YU V. KENIKSFEST, YE I. STUKOVA, YE B. KORYUKINA, and S. V. VEDERNIKOVA. "Different drug forms of methylprednisolone aceponate for the treatment of patients with allergic skin diseases." Vestnik dermatologii i venerologii 89, no. 5 (2013): 138–51. http://dx.doi.org/10.25208/vdv603.

Full text
Abstract:
The article presents the results of the efficacy and safety assessment of the treatment of adult patients suffering from allergic dermatoses with different drug forms of methylprednisolone aceponate 0.1% (Advantan). The authors revealed high efficacy of the treatment of patients with atopic dermatitis and generalized eczema with the achievement of clinical remission and regression of the EASI index by 88.6-88.8% from the baseline level after three weeks of the drug administration; in patients with hand eczema after four weeks of treatment, and in patients with allergic dermatitis - after exter
APA, Harvard, Vancouver, ISO, and other styles
3

Dvoryankova, E. V. "Steroidophobia in dermatology - contemporary problem of the past." Vestnik dermatologii i venerologii 91, no. 3 (2015): 131–34. http://dx.doi.org/10.25208/0042-4609-2015-91-3-131-134.

Full text
Abstract:
Topical steroids are the first-line drugs for the treatment of the majority of dermatological diseases. Currently, however, often we have to deal with steroidophobia both among patients and doctors. The problem has been actively studied since steroidophobia can significantly reduce the quality of the treatment. At the same time, with the use of modern topical steroids, such as Advantan, steroidophobia has no grounds due to the high level of safety under normal use of drugs.
APA, Harvard, Vancouver, ISO, and other styles
4

Kotrekhova, L. P., and A. A. Vashkevich. "An experience of using methylprednisolone aceponate in the therapy of lupus erythematosus tumidus." Vestnik dermatologii i venerologii 91, no. 4 (2015): 132–36. http://dx.doi.org/10.25208/0042-4609-2015-91-4-132-136.

Full text
Abstract:
Lupus erythematosus tumidus is a rare skin form of lupus erythematosus. About 250 cases of lupus erythematosus tumidus have been described in the world by now. A specific clinical sign of this dermatosis is the appearance of annular or arcuate urticaria-like rash. As a rule, the appearance of the rash is preceded by ultraviolet irradiation. The administration of glucocorticosteroid drugs of local action belonging to classes of potent and very potent steroids is the first-line therapy for lupus erythematosus tumidus. The authors describe a case of the successful treatment of lupus erythematosus
APA, Harvard, Vancouver, ISO, and other styles
5

Kim, Chonghyeok, Byeongdeog Kang, Youngchul Kye, and Soonam Kim. "Clinical Investigation on the Therapeutic Efficacy of Methylprednisolone Aceponate(MPA, Advantan®) 0.1% Ointment in various forms of Eczema." Journal of Korean Society for Clinical Pharmacology and Therapeutics 2, no. 2 (1994): 167. http://dx.doi.org/10.12793/jkscpt.1994.2.2.167.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Niedner, R., and R. P. Zaumseil. "Advantan® Milch/Creme/Salbe bei Kindern mit atopischer Dermatitis und anderen entzündlich-ekzematösen Dermatosen. Eine Anwendungsbeobachtung bei 558 Kindern." Aktuelle Dermatologie 30, no. 6 (2004): 200–203. http://dx.doi.org/10.1055/s-2004-814472.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Nevozinskaya, Z. A., L. R. Sakaniya, and I. M. Korsunskaya. "Hand eczema: a common diagnosis in everyday practice." Meditsinskiy sovet = Medical Council, no. 2 (March 7, 2024): 98–102. http://dx.doi.org/10.21518/ms2024-033.

Full text
Abstract:
Hand eczema is one of the most common dermatoses at the doctor’s office during visits. There is some evidence that the prevalence rates reach almost 15% of the population. This disease greatly affects patients’ quality of life, work activities and other areas of life. The eczema pathogenesis is quite complex and is built up of genetic factors, environmental effects and various irritating agents. Disturbances of skin barrier also plays a significant role in the development of the disease. For example, patients with atopic dermatitis often suffer from hand eczema. Excessive hand hygiene (frequen
APA, Harvard, Vancouver, ISO, and other styles
8

Günther, C., A. Kecskes, T. Staks, and U. Täuber. "Percutaneous Absorption of Methylprednisolone Aceponate following Topical Application of Advantan® Lotion on Intact, Inflamed and Stripped Skin of Male Volunteers." Skin Pharmacology and Physiology 11, no. 1 (1998): 35–42. http://dx.doi.org/10.1159/000029806.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Chikin, V. V. "Topical methylprednisolone aceponate and dexpanthenol in the treatment of patients with atopic dermatitis." Vestnik dermatologii i venerologii 90, no. 5 (2014): 112–16. http://dx.doi.org/10.25208/0042-4609-2014-90-5-112-116.

Full text
Abstract:
The goals of the topical treatment of patients suffering from atopic dermatitis are suppression of the inflammatory reaction in the skin, elimination of itching, and recovery of the damaged protective lipid barrier of the epidermis. In this connection, topical glucocorticosteroids and skin moisturizers are used in the therapy of patients suffering from atopic dermatitis. Methylprednisolone aceponate (MPA, Advantan) being a topical glucocorticosteroid is characterized by high efficacy and safety. MPA is marked by the fast development of the therapeutic effect. This drug can be used for children
APA, Harvard, Vancouver, ISO, and other styles
10

Estrada, Alejandro, Erika Ramirez, Mirna Toledo, et al. "Metilprednisolone and dialyzable leukocytes extracts induce changes in frequency of CLA+ T cells in patients with atopic dermatitis (P4196)." Journal of Immunology 190, no. 1_Supplement (2013): 48.8. http://dx.doi.org/10.4049/jimmunol.190.supp.48.8.

Full text
Abstract:
Abstract Atopic dermatitis(AD) is a T cell-mediated skin disease associated with a Th2 local response and skin inflammation is associated with CLA expression. In this work we evaluated expression of CLA on CD4 and CD8 T cells in 2 groups of patients one of them received metilprednisolone(mP-Advantan-) as treatment(Group 1) and second group received mP and dialyzable leukocyte extracts(DLE-Transferon-) as immune modulator(Group 2). Methods: Double blind randomized placebo controlled study, approved by hospital ethical committee. PBMC were obtained before, during (14 day) and at the end of treat
APA, Harvard, Vancouver, ISO, and other styles
11

M. Vijayalakshmi, M. Vijayalakshmi, and Dr P. Natarajan Dr. P. Natarajan. "Strategic Human Resource Management for Competitive Advantag." Indian Journal of Applied Research 2, no. 1 (2011): 24–27. http://dx.doi.org/10.15373/2249555x/oct2012/10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Fezza, John P. "Advanta Implants." Facial Plastic Surgery 20, no. 02 (2004): 185–89. http://dx.doi.org/10.1055/s-2004-861763.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Gray, Colin S. "Moral Advantage, Strategic Advantage?" Journal of Strategic Studies 33, no. 3 (2010): 333–65. http://dx.doi.org/10.1080/01402391003750010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

董, 雅萌. "Transform Party Building Advantage into Enterprise Competitive Advantage, Innovation Advantage and Development Advantage." Advances in Social Sciences 11, no. 04 (2022): 1455–60. http://dx.doi.org/10.12677/ass.2022.114198.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

董, 雅萌. "Transform Party Building Advantage into Enterprise Competitive Advantage, Innovation Advantage and Development Advantage." Advances in Social Sciences 11, no. 04 (2022): 1455–60. http://dx.doi.org/10.12677/ass.2022.114198.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

P.B REDDY, P. B. REDDY, M. VENKATA M VENKATA, and Dr MORUSU SIVA SANKAR Dr MORUSU SIVA SANKAR. "Advantage Of Image Management." International Journal of Scientific Research 3, no. 1 (2012): 71–73. http://dx.doi.org/10.15373/22778179/jan2014/25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Niamtu, Joseph. "Advanta Facial Implants." Oral and Maxillofacial Surgery Clinics of North America 17, no. 1 (2005): 29–39. http://dx.doi.org/10.1016/j.coms.2004.09.007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

BURDETT, K., and J. WALSH. "EXPLOITING AN ADVANTAGE--DECLINING AN ADVANTAGE." Oxford Economic Papers 49, no. 1 (1997): 21–28. http://dx.doi.org/10.1093/oxfordjournals.oep.a028594.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Newhouse, Joseph P., Mary Beth Landrum, Mary Price, J. Michael McWilliams, John Hsu, and Thomas G. McGuire. "The Comparative Advantage of Medicare Advantage." American Journal of Health Economics 5, no. 2 (2019): 281–301. http://dx.doi.org/10.1162/ajhe_a_00120.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Park, Soonchan. "ICT Development and Comparative Advantage." Korean Journal of EU Studies 29, no. 3 (2024): 5–24. https://doi.org/10.38158/kjeus.29.3.1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Doddy Sukma Wirawan. "Analisis Keunggulan Bersaing Terhadap Kinerja Bisnis Yang Berkelanjutan (Studi Kasus Yayasan Sekolah Daya Utama Kota Bekasi)." Jurnal Akutansi Manajemen Ekonomi Kewirausahaan (JAMEK) 2, no. 3 (2022): 238–46. http://dx.doi.org/10.47065/jamek.v2i3.352.

Full text
Abstract:
This research is about the Analysis of Competitive Advantage on Sustainable Business Performance. The purpose of this study was to determine the effect of organizational capability and innovation to achieve competitive advantage on sustainable business performance (a study at the Daya Utama School Foundation in Bekasi City). Engaged in education starting from elementary, junior high, high school and vocational education levels. The sampling technique uses purposive sampling, amounting to 30 respondents. Data collection using a questionnaire. Data analysis techniques using Structural Equation M
APA, Harvard, Vancouver, ISO, and other styles
22

Zurk, Lisa M., Barbara Simons, Rebecca Parsons, and Dawn Cohen. "When an advantage is not an advantage." Communications of the ACM 38, no. 12 (1995): 17–18. http://dx.doi.org/10.1145/219663.219667.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

O'Shannassy, Tim. "Sustainable competitive advantage or temporary competitive advantage." Journal of Strategy and Management 1, no. 2 (2008): 168–80. http://dx.doi.org/10.1108/17554250810926357.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

KAWECKI, Kamil. "Maintaining competetive advantage – organization renewal perspective." Scientific Papers of Silesian University of Technology. Organization and Management Series 2018, no. 118 (2018): 279–90. http://dx.doi.org/10.29119/1641-3466.2018.118.20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Sekhar, AV. "Advantage India - In the Disadvantaged World." International Journal of Science and Research (IJSR) 10, no. 2 (2021): 68–69. https://doi.org/10.21275/sr21128160034.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Seppa, Nathan. "Centenarian Advantage." Science News 164, no. 16 (2003): 243. http://dx.doi.org/10.2307/4019077.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Arnold, Eric. "Electronic Advantage." Musical Times 129, no. 1746 (1988): 386. http://dx.doi.org/10.2307/965959.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Wolf, Charlotte. "Relative Advantage." Symbolic Interaction 13, no. 1 (1990): 37–61. http://dx.doi.org/10.1525/si.1990.13.1.37.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Pikayev, Alexander A. "Unfair advantage." Bulletin of the Atomic Scientists 63, no. 4 (2007): 36. http://dx.doi.org/10.2968/063004012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Margolis, Joseph. "Pragmatism’s Advantage." Ars Disputandi 3, no. 1 (2003): 300–326. http://dx.doi.org/10.1080/15665399.2003.10819799.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Ellory, Clive. "Singular advantage." Nature 323, no. 6090 (1986): 680. http://dx.doi.org/10.1038/323680a0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Parker, Steven A. "Taking Advantage." Cogeneration & Distributed Generation Journal 22, no. 4 (2007): 5. http://dx.doi.org/10.1080/15453660709509127.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Beardsley, Tim. "Advantage: Nature." Scientific American 274, no. 5 (1996): 33. http://dx.doi.org/10.1038/scientificamerican0596-33a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Haake, Steve. "Material advantage?" Physics World 25, no. 07 (2012): 26–30. http://dx.doi.org/10.1088/2058-7058/25/07/33.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Taroni, Andrea. "Competitive advantage." Nature Physics 11, no. 8 (2015): 620. http://dx.doi.org/10.1038/nphys3442.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Czajka, Caitlin. "Acellular advantage." Science 368, no. 6487 (2020): 149.9–150. http://dx.doi.org/10.1126/science.368.6487.149-i.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Jüttner, Uta, and Hans Peter Wehrli. "Competitive Advantage." Journal of Business & Industrial Marketing 9, no. 4 (1994): 42–53. http://dx.doi.org/10.1108/08858629410073199.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

SHAANKER, R. UMA, and K. N. GANESHAIAH. "Sexual advantage." Nature 337, no. 6206 (1989): 413. http://dx.doi.org/10.1038/337413b0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

KELLEY, STEVEN E., JANIS ANTONOVICS, and JOHANNA SCHMITT. "Sexual advantage." Nature 337, no. 6206 (1989): 413–14. http://dx.doi.org/10.1038/337413c0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Pennisi, Elizabeth. "Magnetic Advantage." Science News 142, no. 9 (1992): 140. http://dx.doi.org/10.2307/3976782.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Ruthen, Russell. "Clear Advantage." Scientific American 265, no. 3 (1991): 48–53. http://dx.doi.org/10.1038/scientificamerican0991-48.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Miller, Saul. "Capital advantage." British Journal of General Practice 74, no. 744 (2024): 325. http://dx.doi.org/10.3399/bjgp24x738729.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Blough, Genie G., and Stephen E. Comess. "Take Advantage!" ASA Monitor 82, no. 6 (2018): 30–32. https://doi.org/10.1097/01.asm.0001077000.94996.b6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Kamukama, Nixon, Diana Susan Kyomuhangi, Richard Akisimire, and Laura A. Orobia. "Competitive advantage." African Journal of Economic and Management Studies 8, no. 2 (2017): 221–34. http://dx.doi.org/10.1108/ajems-10-2016-0142.

Full text
Abstract:
Purpose The purpose of this paper is to examine the mediating role of competitive advantage in the relationship between managerial competence and financial performance of commercial banks in Uganda. Design/methodology/approach A cross-sectional survey was employed using 22 fully licensed and operational commercial banks in Uganda. Data were analyzed using descriptive statistics, zero order correlation and hierarchical regression analyses. Further, the bootstrap method was used to test the mediation effect of competitive advantage. All the analyses were performed using SPSS v21. Findings The fi
APA, Harvard, Vancouver, ISO, and other styles
45

Martin, Xavier. "Institutional Advantage." Global Strategy Journal 4, no. 1 (2014): 55–69. http://dx.doi.org/10.1111/j.2042-5805.2013.01072.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Downs, Christian. "Take Advantage." Oncology Issues 24, no. 5 (2009): 4. http://dx.doi.org/10.1080/10463356.2009.11883446.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Casey, Michelle, and Barbara Yawn. "Missouri Advantage." Journal of Rural Health 14, no. 3 (1998): 257–67. http://dx.doi.org/10.1111/j.1748-0361.1998.tb00627.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Won, Rachel. "Aperiodic advantage." Nature Photonics 7, no. 12 (2013): 938–39. http://dx.doi.org/10.1038/nphoton.2013.333.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Zuk, M. "Avian Advantage." Science 267, no. 5197 (1995): 548–49. http://dx.doi.org/10.1126/science.267.5197.548-a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Beckman, M. "Centenarian Advantage." Science of Aging Knowledge Environment 2003, no. 46 (2003): 155nw—155. http://dx.doi.org/10.1126/sageke.2003.46.nw155.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!